Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy

We aimed to determine the prognostic value of α-hydroxybutyrate dehydrogenase (α-HBDH) in upper tract urothelial carcinoma (UTUC) patients after radical nephroureterectomy (RNU).

Source: BMC Urology - March 20, 2024 Category: Urology & Nephrology Authors: Jianjun Ye, Lei Zheng, Zeyu Chen, Qihao Wang, Xinyang Liao, Xingyuan Wang, Qiang Wei and Yige Bao Tags: Research Source Type: research